1. ACTR-40. PHASE 2 SAFETY AND EFFICACY OF AR-67 (7-T-BUTYLDIMETHYLSILTYL-10-HYDROXYCAMPTOTHECIN) IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA. (11th November 2019) Authors: Kumthekar, Priya; Raizer, Jeffrey; Cavaliere, Robert; Devoe, Craig; Jensen, Randy; Stieber, Volker; Runk, Tina; Grewal, Jai; Brownell, Elise; Zukiwski, Alex; Proniuk, Stefan; Arnold, Susanne; Vredenburgh, James Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTNI-45. RESPONSE EVALUATION OF AR-67 FROM A PHASE-2 RECURRENT GLIOBLASTOMA TRIAL BY ARTIFICIAL INTELLIGENCE ASSISTED TUMOR VOLUMETRIC ESTIMATION: COMPARISON WITH THE SUM OF THE PERPENDICULAR DIAMETERS PRODUCT. (12th November 2021) Authors: Bisdas, Sotirios; Grewal, Jai; Stieber, Volker; Cavaliere, Robert; Devoe, Craig; Jensen, Randy; Brownell, Elise; Runk, Tina; Dupont-Roettger, Diana Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗